Beneficial effects of statins on the rates of hepatic fibrosis, hepatic decompensation, and mortality in chronic liver disease: a systematic review and meta-analysis | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Beneficial effects of statins on the rates of hepatic fibrosis, hepatic decompensation, and mortality in chronic liver disease: a systematic review and meta-analysis

Kamal S, Khan MAli, Seth A, Cholankeril G, Gupta D, Singh U, et al. Beneficial effects of statins on the rates of hepatic fibrosis, hepatic decompensation, and mortality in chronic liver disease: a systematic review and meta-analysis. Am J Gastroenterol. 2017;112(10):1495-1505.

Publication Type:

Journal Article

Authors:

Kamal, Sehrish; Khan, Muhammad Ali; Seth, Ankur; Cholankeril, George; Gupta, Deepansh; Singh, Utkarsh; Kamal, Faisal; Howden, Colin W.; Stave, Christopher; Nair, Satheesh; Satapathy, Sanjaya K.; Ahmed, Aijaz

Source:

Am J Gastroenterol, Volume 112, Issue 10, p.1495-1505 (2017)

Keywords:

Chronic Disease, Disease Progression, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Liver Cirrhosis, Liver Diseases, Liver Failure, Observational Studies as Topic, Survival Analysis, Treatment Outcome

Cited On:

External Third-party Web Link:

http://www.ncbi.nlm.nih.gov/pubmed/28585556

Export Citation:

RIS Format

Top